Moreover, decreased MYC protein levels may potentially have downstream effects which render MM cells more susceptible towards the activity of immune cells, since MYC also regulates anti-tumor immunity through CD47 and PD-L1 in vivo (221). Here, CD274 is linked to Miyoshi myopathy.